Exact Sciences (EXAS) Tops Q3 EPS by 7c; Guides Above Views

Go back to Exact Sciences (EXAS) Tops Q3 EPS by 7c; Guides Above Views

BTIG Downgrades Exact Sciences (EXAS) to Neutral

November 1, 2017 6:33 AM EDT

BTIG downgraded Exact Sciences (NASDAQ: EXAS) from Buy to Neutral.

Analyst Sean Lavin believes the risk/reward is balanced and downgrades the stock while stating "we cna't just keep raising out price target." The analyst sees ways for the equity to appreciate but... More

Exact Sciences (EXAS) PT Raised to $61 at Craig-Hallum

October 31, 2017 7:24 AM EDT

Craig-Hallum analyst Kevin Ellich raised his price target on Exact Sciences (NASDAQ: EXAS) to $61.00 while maintaining a Buy rating following strong beat and raise results.

... More

Exact Sciences (EXAS) PT Raised to $54 at Stephens

October 31, 2017 5:59 AM EDT

Stephens raised its price target on Exact Sciences (NASDAQ: EXAS) to $54.00 (from $36.00) while maintaining a Equal Weight rating.

Analyst Drew Jones liked the Q4 report and regrets missing the recent appreciation. The analyst remains sidelined and won't chase the equity citing... More